HRP930964B1 - Therapeutic triazine compounds and the use thereof - Google Patents

Therapeutic triazine compounds and the use thereof

Info

Publication number
HRP930964B1
HRP930964B1 HR930964A HRP930964A HRP930964B1 HR P930964 B1 HRP930964 B1 HR P930964B1 HR 930964 A HR930964 A HR 930964A HR P930964 A HRP930964 A HR P930964A HR P930964 B1 HRP930964 B1 HR P930964B1
Authority
HR
Croatia
Prior art keywords
pct
therapeutic
date dec
triazine compounds
sec
Prior art date
Application number
HR930964A
Other languages
English (en)
Inventor
Meire Nakamura-Craig
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929212495A external-priority patent/GB9212495D0/en
Priority claimed from GB939308654A external-priority patent/GB9308654D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HRP930964A2 publication Critical patent/HRP930964A2/xx
Publication of HRP930964B1 publication Critical patent/HRP930964B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR930964A 1992-06-12 1993-06-11 Therapeutic triazine compounds and the use thereof HRP930964B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929212495A GB9212495D0 (de) 1992-06-12 1992-06-12
GB939308654A GB9308654D0 (en) 1993-04-27 1993-04-27 Therapeutic triazine compounds and use

Publications (2)

Publication Number Publication Date
HRP930964A2 HRP930964A2 (en) 1996-02-29
HRP930964B1 true HRP930964B1 (en) 2000-06-30

Family

ID=26301060

Family Applications (1)

Application Number Title Priority Date Filing Date
HR930964A HRP930964B1 (en) 1992-06-12 1993-06-11 Therapeutic triazine compounds and the use thereof

Country Status (23)

Country Link
US (1) US5801171A (de)
EP (1) EP0644763B1 (de)
JP (1) JP3439211B2 (de)
KR (1) KR100268823B1 (de)
AT (1) ATE147980T1 (de)
AU (1) AU688729B2 (de)
CA (1) CA2137782A1 (de)
CZ (1) CZ284061B6 (de)
DE (1) DE69307705T2 (de)
DK (1) DK0644763T3 (de)
ES (1) ES2097516T3 (de)
GB (1) GB2282326A (de)
GR (1) GR3022671T3 (de)
HR (1) HRP930964B1 (de)
IL (1) IL105986A (de)
MY (1) MY109330A (de)
NO (1) NO306451B1 (de)
NZ (1) NZ253260A (de)
SI (1) SI9300318A (de)
SK (1) SK279730B6 (de)
TW (1) TW284689B (de)
WO (1) WO1993025207A1 (de)
YU (1) YU48573B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS234018B2 (en) * 1979-06-01 1985-03-14 Wellcome Found Method of 3,5-diammino-6-1,2,4-triazine derivatives making
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
ATE147980T1 (de) 1997-02-15
EP0644763B1 (de) 1997-01-22
KR100268823B1 (ko) 2000-12-01
DK0644763T3 (da) 1997-07-28
DE69307705T2 (de) 1997-05-22
NO306451B1 (no) 1999-11-08
CZ312894A3 (en) 1995-07-12
CA2137782A1 (en) 1993-12-23
HRP930964A2 (en) 1996-02-29
YU48573B (sh) 1998-12-23
SK279730B6 (sk) 1999-02-11
AU4345293A (en) 1994-01-04
AU688729B2 (en) 1998-03-19
IL105986A0 (en) 1993-10-20
US5801171A (en) 1998-09-01
NZ253260A (en) 1997-05-26
SI9300318A (en) 1994-03-31
WO1993025207A1 (en) 1993-12-23
DE69307705D1 (de) 1997-03-06
IL105986A (en) 1998-12-06
TW284689B (de) 1996-09-01
CZ284061B6 (cs) 1998-08-12
JPH07507790A (ja) 1995-08-31
ES2097516T3 (es) 1997-04-01
GR3022671T3 (en) 1997-05-31
JP3439211B2 (ja) 2003-08-25
EP0644763A1 (de) 1995-03-29
SK153494A3 (en) 1996-01-10
NO944790L (no) 1994-12-09
GB9423697D0 (en) 1995-01-11
YU41093A (sh) 1996-10-09
MY109330A (en) 1997-01-31
KR950701814A (ko) 1995-05-17
NO944790D0 (no) 1994-12-09
GB2282326A (en) 1995-04-05

Similar Documents

Publication Publication Date Title
MY103536A (en) New use of 5 ht-3 antagonists
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
MXPA98005325A (es) Pirazoles y pirazolopirimidinas.
GR3034765T3 (en) Corticotropin releasing factor antagonists
GB9317636D0 (en) Use of dexmedetomidine
EP0642347A4 (de) Verwendung von 2-halo-adeninderivaten als therapeutische wirkstoffe gegen chronisch-myeloische leukämie.
EP0661972A4 (de) Verwendung von spiperon und spiperonderivaten als immunsuppressive wirkstoffe.
TW226331B (de)
HRP930964B1 (en) Therapeutic triazine compounds and the use thereof
MY110149A (en) Compounds for the treatment of neurodegenerative disorders
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
IL103204A0 (en) Neuroleptic 2-substituted perhydro-1-h-pyrido(1,2-a)pyrazines
MX9603999A (es) Tratamiento de nefropatia diabetica con valsartan.
IL101284A (en) 2-arylimidazo 1, 5-a9 quinoxaline-1, 3(2h, 5h)-diones certain derivatives of tautomers thereof use of such compounds in the manufacture of medicaments and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20000611

Year of fee payment: 8

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20010612